Vir Biotechnology Stock Technical Analysis
| VIR Stock | USD 7.19 0.27 3.90% |
As of the 9th of February, Vir Biotechnology has the Coefficient Of Variation of 945.88, risk adjusted performance of 0.0934, and Semi Deviation of 3.52. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vir Biotechnology, as well as the relationship between them. Please validate Vir Biotechnology jensen alpha and semi variance to decide if Vir Biotechnology is priced more or less accurately, providing market reflects its prevalent price of 7.19 per share. Given that Vir Biotechnology has jensen alpha of 0.325, we advise you to double-check Vir Biotechnology's current market performance to make sure the company can sustain itself at a future point.
Vir Biotechnology Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vir, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VirVir Biotechnology's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Vir Biotechnology Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 16.33 | Buy | 9 | Odds |
Most Vir analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vir stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vir Biotechnology, talking to its executives and customers, or listening to Vir conference calls.
Can Biotechnology industry sustain growth momentum? Does Vir have expansion opportunities? Factors like these will boost the valuation of Vir Biotechnology. If investors know Vir will grow in the future, the company's valuation will be higher. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Vir Biotechnology demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Quarterly Earnings Growth 0.585 | Earnings Share (3.62) | Revenue Per Share | Quarterly Revenue Growth (0.90) | Return On Assets |
Vir Biotechnology's market price often diverges from its book value, the accounting figure shown on Vir's balance sheet. Smart investors calculate Vir Biotechnology's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Vir Biotechnology's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Vir Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vir Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vir Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vir Biotechnology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vir Biotechnology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vir Biotechnology.
| 11/11/2025 |
| 02/09/2026 |
If you would invest 0.00 in Vir Biotechnology on November 11, 2025 and sell it all today you would earn a total of 0.00 from holding Vir Biotechnology or generate 0.0% return on investment in Vir Biotechnology over 90 days. Vir Biotechnology is related to or competes with Maravai Lifesciences, Iovance Biotherapeutics, Replimune, Prime Medicine, Ginkgo Bioworks, Geron, and LENZ Therapeutics. Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serio... More
Vir Biotechnology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vir Biotechnology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vir Biotechnology upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.93 | |||
| Information Ratio | 0.0859 | |||
| Maximum Drawdown | 23.4 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 8.08 |
Vir Biotechnology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vir Biotechnology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vir Biotechnology's standard deviation. In reality, there are many statistical measures that can use Vir Biotechnology historical prices to predict the future Vir Biotechnology's volatility.| Risk Adjusted Performance | 0.0934 | |||
| Jensen Alpha | 0.325 | |||
| Total Risk Alpha | 0.021 | |||
| Sortino Ratio | 0.0988 | |||
| Treynor Ratio | 0.2606 |
Vir Biotechnology February 9, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0934 | |||
| Market Risk Adjusted Performance | 0.2706 | |||
| Mean Deviation | 3.46 | |||
| Semi Deviation | 3.52 | |||
| Downside Deviation | 3.93 | |||
| Coefficient Of Variation | 945.88 | |||
| Standard Deviation | 4.52 | |||
| Variance | 20.45 | |||
| Information Ratio | 0.0859 | |||
| Jensen Alpha | 0.325 | |||
| Total Risk Alpha | 0.021 | |||
| Sortino Ratio | 0.0988 | |||
| Treynor Ratio | 0.2606 | |||
| Maximum Drawdown | 23.4 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 8.08 | |||
| Downside Variance | 15.46 | |||
| Semi Variance | 12.4 | |||
| Expected Short fall | (3.92) | |||
| Skewness | 0.6323 | |||
| Kurtosis | 1.18 |
Vir Biotechnology Backtested Returns
Vir Biotechnology appears to be slightly risky, given 3 months investment horizon. Vir Biotechnology owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.11, which indicates the firm had a 0.11 % return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Vir Biotechnology, which you can use to evaluate the volatility of the company. Please review Vir Biotechnology's Coefficient Of Variation of 945.88, risk adjusted performance of 0.0934, and Semi Deviation of 3.52 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Vir Biotechnology holds a performance score of 8. The entity has a beta of 1.8, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vir Biotechnology will likely underperform. Please check Vir Biotechnology's sortino ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to make a quick decision on whether Vir Biotechnology's existing price patterns will revert.
Auto-correlation | 0.69 |
Good predictability
Vir Biotechnology has good predictability. Overlapping area represents the amount of predictability between Vir Biotechnology time series from 11th of November 2025 to 26th of December 2025 and 26th of December 2025 to 9th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vir Biotechnology price movement. The serial correlation of 0.69 indicates that around 69.0% of current Vir Biotechnology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.69 | |
| Spearman Rank Test | 0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 0.53 |
Vir Biotechnology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Vir Biotechnology Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vir Biotechnology volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Vir Biotechnology Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vir Biotechnology on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vir Biotechnology based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vir Biotechnology price pattern first instead of the macroeconomic environment surrounding Vir Biotechnology. By analyzing Vir Biotechnology's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vir Biotechnology's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vir Biotechnology specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 0.93 | 0.72 | 0.65 | 0.5 | Revenue Per Share | 0.64 | 0.54 | 0.49 | 0.47 |
Vir Biotechnology February 9, 2026 Technical Indicators
Most technical analysis of Vir help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vir from various momentum indicators to cycle indicators. When you analyze Vir charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0934 | |||
| Market Risk Adjusted Performance | 0.2706 | |||
| Mean Deviation | 3.46 | |||
| Semi Deviation | 3.52 | |||
| Downside Deviation | 3.93 | |||
| Coefficient Of Variation | 945.88 | |||
| Standard Deviation | 4.52 | |||
| Variance | 20.45 | |||
| Information Ratio | 0.0859 | |||
| Jensen Alpha | 0.325 | |||
| Total Risk Alpha | 0.021 | |||
| Sortino Ratio | 0.0988 | |||
| Treynor Ratio | 0.2606 | |||
| Maximum Drawdown | 23.4 | |||
| Value At Risk | (6.25) | |||
| Potential Upside | 8.08 | |||
| Downside Variance | 15.46 | |||
| Semi Variance | 12.4 | |||
| Expected Short fall | (3.92) | |||
| Skewness | 0.6323 | |||
| Kurtosis | 1.18 |
Vir Biotechnology February 9, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Vir stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | 0.56 | ||
| Rate Of Daily Change | 1.04 | ||
| Day Median Price | 7.16 | ||
| Day Typical Price | 7.17 | ||
| Price Action Indicator | 0.17 | ||
| Market Facilitation Index | 0.48 |
Additional Tools for Vir Stock Analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.